Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives
- PMID: 1974510
- DOI: 10.1007/BF01409490
Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives
Abstract
Carvedilol and nitrendipine were given for 12 weeks in a double-blind study to 81 elderly patients (greater than or equal to 60 years) with essential hypertension. The effects on blood pressure were measured (Riva Rocci) before medication and after 2 h with the patient in a lying and standing position after 4 weeks of placebo therapy as well as after 4, 8 and 12 weeks of treatment. Carvedilol (25 mg/o.d.) reduced blood pressure measured in the supine and erect position very successfully, similar to the reduction achieved with nitrendipine (20 mg/o.d.), without influencing the pulse rate. Both substances were well tolerated. Carvedilol is an alternative substance for lowering high blood pressure in elderly hypertensive patients.
Similar articles
-
The use of carvedilol in elderly hypertensive patients.Eur J Clin Pharmacol. 1990;38 Suppl 2:S129-33. doi: 10.1007/BF01409482. Eur J Clin Pharmacol. 1990. PMID: 1974503 Clinical Trial.
-
Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.Drugs. 1988;36 Suppl 6:92-101. doi: 10.2165/00003495-198800366-00016. Drugs. 1988. PMID: 2908307 Clinical Trial.
-
Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.Eur J Clin Pharmacol. 1990;38 Suppl 2:S147-52. doi: 10.1007/BF01409486. Eur J Clin Pharmacol. 1990. PMID: 1974506 Clinical Trial.
-
Use of carvedilol in hypertension: an update.Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Vasc Health Risk Manag. 2012. PMID: 22661898 Free PMC article. Review.
-
Clinical experience with carvedilol.J Hum Hypertens. 1993 Feb;7 Suppl 1:S16-20. J Hum Hypertens. 1993. PMID: 8098064 Review.
Cited by
-
Acute hemodynamic effects of carvedilol in comparison with propranolol in patients with coronary heart disease.Clin Investig. 1992;70 Suppl 1:S93-7. doi: 10.1007/BF00207618. Clin Investig. 1992. PMID: 1350491 Clinical Trial.
-
A double-blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.Eur J Clin Pharmacol. 1993;45(2):95-100. doi: 10.1007/BF00315487. Eur J Clin Pharmacol. 1993. PMID: 8223847 Clinical Trial.
-
Antihypertensive profile of carvedilol.Clin Investig. 1992;70 Suppl 1:S43-52. doi: 10.1007/BF00207611. Clin Investig. 1992. PMID: 1350484 Review.
-
Clinical pharmacokinetics and pharmacodynamics of carvedilol.Clin Pharmacokinet. 1994 May;26(5):335-46. doi: 10.2165/00003088-199426050-00002. Clin Pharmacokinet. 1994. PMID: 7914479 Review.
-
Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1993 Feb;45(2):232-58. doi: 10.2165/00003495-199345020-00006. Drugs. 1993. PMID: 7681374 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical